Antibodies that recognize and bind to DNA (anti-DNA antibodies) are serological hallmarks
of systemic lupus erythematosus (SLE) and key markers for diagnosis and disease activity …

Antinuclear antibodies (ANAs) are a diverse group of autoantibodies that recognize nuclear
macromolecules and their complexes. ANAs represent key biomarkers in the evaluation of …

Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by a
breakdown of self-tolerance, production of auto-antibodies and immune-mediated injury …

Objective To define and identify a group of systemic lupus erythematosus patients with low
disease activity (LDA) and to examine whether LDA is similar to patients in remission and …

Autoantibodies are a key component for the diagnosis, prognosis and monitoring of various
diseases. In order to discover novel autoantibody targets, highly multiplexed assays based …

Systemic lupus erythematosus (SLE) is a prototypical systemic autoimmune disease that
represents a great challenge for current therapy as well as new drug development (1, 2) …

Systemic lupus erythematosus is a complex autoimmune disease affecting multiple organ
systems. Currently, diagnosis relies upon meeting at least four out of eleven criteria outlined …

Anti–double‐stranded DNA antibodies (anti‐dsDNA) are considered a specific marker for
systemic lupus erythematosus (SLE). Though the Farr technique was once the reference …

Introduction. The objective of the present study was to compare QUANTA Flash dsDNA, a
chemiluminescent immunoassay (CIA) on the BIO‐FLASH, a rapid‐response …

Objective: Anti-double stranded desoxyribonucleic acid (anti-dsDNA) antibodies are
considered fairly specific for systemic lupus erythematosus (SLE) and their quantification is …